G. Heusch, P. Libby, B. Gersh, D. Yellon, M. Bohm et al., Cardiovascular remodelling in coronary artery disease and heart failure, Pubmed Central, vol.383, issue.9932, p.24831770, 2014.

R. A. Brown, E. Shantsila, C. Varma, and G. Y. Lip, Current understanding of atherogenesis, Am. J. Med, vol.130, issue.3, 2017.

M. Scheidt, Y. Zhao, Z. Kurt, C. Pan, L. Zeng et al., Applications and limitations of mouse models for understanding human atherosclerosis, Cell Metabolism, vol.25, issue.2, p.27916529, 2017.

F. Lang, E. Ritz, I. Alesutan, and J. Voelkl, Impact of aldosterone on osteoinductive signaling and vascular calcification, Nephron. Physiol, vol.128, issue.1e2, 2014.

J. F. Polak, M. J. Pencina, K. M. Pencina, C. J. O'donnell, P. A. Wolf et al., Carotid-wall intima-media thickness and cardiovascular events, N. Engl. J. Med, vol.365, issue.3, 2011.

O. A. Centurion, Carotid intima-media thickness as a cardiovascular risk factor and imaging pathway of atherosclerosis, Crit. Pathw. Cardiol, vol.15, issue.4, 2016.

D. Graham, M. W. Mcbride, M. Gaasenbeek, K. Gilday, E. Beattie et al., Candidate genes that determine response to salt in the stroke-prone spontaneously hypertensive rat: congenic analysis, Hypertension, vol.50, issue.6, 2007.

G. S. Getz and C. A. Reardon, Animal models of atherosclerosis, Arterioscler. Thromb. Vasc. Biol, vol.32, issue.5, 2012.

H. H. Koh-tan, M. Dashti, T. Wang, W. Beattie, J. Mcclure et al., Dissecting the genetic components of a quantitative trait locus for blood pressure and renal pathology on rat chromosome 3, J. Hypertens, vol.35, issue.2, 2017.

, Feb) 319e329. Pubmed Central, 27755386.

M. Kuro-o, Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga et al., Mutation of the mouse klotho gene leads to a syndrome resembling ageing, Nature, vol.390, issue.6655, pp.45-51, 1997.

H. Kurosu, M. Yamamoto, J. D. Clark, J. V. Pastor, A. Nandi et al., Suppression of aging in mice by the hormone Klotho, Pubmed Central, vol.309, issue.5742, 2005.

R. Kleemann, S. Zadelaar, and T. Kooistra, Cytokines and atherosclerosis: a comprehensive review of studies in mice, Cardiovasc. Res, vol.79, issue.3, p.18487233, 2008.

A. Soliman and P. Kee, Experimental models investigating the inflammatory basis of atherosclerosis, Curr. Atherosclerosis Rep, vol.10, issue.3, 2008.

R. Laaksonen, Identifying new risk markers and potential targets for coronary artery disease: the value of the lipidome and metabolome, Cardiovasc, Drugs Ther, vol.30, issue.1, 2016.

A. C. Dona, S. Coffey, and G. Figtree, Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment, Eur. J. Prev. Cardiol, vol.23, issue.15, 2016.

J. R. Ussher, S. Elmariah, R. E. Gerszten, and J. R. Dyck, The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease, J. Am. Coll. Cardiol, vol.68, issue.25, 2016.

B. Kowall, N. Ebert, C. Then, J. Thiery, W. Koenig et al., Associations between blood glucose and carotid intima-media thickness disappear after adjustment for shared risk factors: the KORA F4 study, Pubmed Central, vol.7, issue.12, p.52590, 2012.

L. Pfeiffer, S. Wahl, L. C. Pilling, E. Reischl, J. K. Sandling et al., DNA methylation of lipid-related genes affects blood lipid levels, Apr) 334e342. Pubmed Central, vol.8, issue.2, 2015.

C. B. Leibrock, I. Alesutan, J. Voelkl, T. Pakladok, D. Michael et al., NH4Cl treatment prevents tissue calcification in klotho deficiency, J. Am. Soc. Nephrol.: JASN (J. Am. Soc. Nephrol.), vol.26, issue.10, 2015.

B. Jeffs, C. D. Negrin, D. Graham, J. S. Clark, N. H. Anderson et al., Applicability of a "speed" congenic strategy to dissect blood pressure quantitative trait loci on rat chromosome 2, Hypertension, vol.35, issue.1, 2000.

H. H. Koh-tan, M. W. Mcbride, J. D. Mcclure, E. Beattie, B. Young et al., Interaction between chromosome 2 and 3 regulates pulse pressure in the stroke-prone spontaneously hypertensive rat, Hypertension, vol.62, issue.1, 2013.

J. S. Ried, H. Baurecht, F. Stuckler, J. Krumsiek, C. Gieger et al., Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma, Allergy, vol.68, issue.5, 2013.

T. Koal, K. Klavins, D. Seppi, G. Kemmler, and C. Humpel, Sphingomyelin SM(d18: 1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-beta42, tau, and phospho-tau-181 levels, J. Alzheim. Dis.: JAD, vol.44, issue.4, pp.1193-1201, 2015.

K. Klavins, T. Koal, G. Dallmann, J. Marksteiner, G. Kemmler et al., The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment, Alzheimer's Dementia, vol.1, issue.3, pp.295-302, 2015.

L. St-john-williams, C. Blach, J. B. Toledo, D. M. Rotroff, S. Kim et al., Targeted metabolomics and medication classification data from participants in the ADNI1 cohort, 170140. Pubmed Central, vol.4, p.29039849, 2017.

G. Kolovou, V. Kolovou, and S. Mavrogeni, Lipidomics in vascular health: current perspectives, Vasc. Health Risk Manag, vol.11, pp.333-342, 2015.

Y. Chen, S. Wen, M. Jiang, Y. Zhu, L. Ding et al., Atherosclerotic dyslipidemia revealed by plasma lipidomics on ApoE(-/-) mice fed a high-fat diet, Atherosclerosis, vol.262, 2017.

H. De-leon, S. Boue, J. Szostak, M. C. Peitsch, and J. Hoeng, Systems biology research into cardiovascular disease: contributions of lipidomics-based approaches to biomarker discovery, Curr. Drug Discov. Technol, vol.12, issue.3, 2015.

X. C. Jiang, F. Paultre, T. A. Pearson, R. G. Reed, C. K. Francis et al., Plasma sphingomyelin level as a risk factor for coronary artery disease, Arterioscler. Thromb. Vasc. Biol, vol.20, issue.12, 2000.

R. L. Wilensky and C. H. Macphee, Lipoprotein-associated phospholipase A(2) and atherosclerosis, Curr. Opin. Lipidol, vol.20, issue.5, 2009.

P. J. Little, M. L. Ballinger, and N. Osman, Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis, Vasc. Health Risk Manag, Pubmed Central PMCID, vol.3, issue.1, p.17583182, 2007.

S. J. Mihalik, B. H. Goodpaster, D. E. Kelley, D. H. Chace, J. Vockley et al., Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity, Pubmed Central, vol.18, issue.9, 2010.

L. D. Roberts, A. Koulman, and J. L. Griffin, Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome, Lancet Diabetes Endocrinol, vol.2, issue.1, 2014.

A. K. Patel, H. S. Suri, J. Singh, D. Kumar, S. Shafique et al., A review on atherosclerotic biology, wall stiffness, physics of elasticity, and its ultrasound-based measurement, Curr. Atherosclerosis Rep, vol.18, issue.12, 2016.

B. E. Veseli, P. Perrotta, G. R. Meyer, L. Roth, C. Van-der-donckt et al., Animal models of atherosclerosis, Eur. J. Pharmacol, vol.816, 2017.

J. Voelkl, I. Alesutan, C. B. Leibrock, L. Quintanilla-martinez, V. Kuhn et al., Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice, Feb) 812e822. Pubmed Central, vol.123, issue.2, 2013.

I. Alesutan, M. Feger, R. Tuffaha, T. Castor, K. Musculus et al., Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine, Cardiovasc. Res, vol.110, issue.3, 2016.

K. Amann, Media calcification and intima calcification are distinct entities in chronic kidney disease, Clin. J. Am. Soc. Nephrol.: CJASN, vol.3, issue.6, 2008.

M. Suarez-diez, J. Adam, J. Adamski, S. A. Chasapi, C. Luchinat et al., Plasma and serum metabolite association networks: comparability within and between studies using NMR and MS profiling, J. Proteome Res, vol.16, issue.7, 2017.

Z. Yu, G. Kastenmuller, Y. He, P. Belcredi, G. Moller et al., Differences between human plasma and serum metabolite profiles, PLoS One, vol.6, issue.7, p.21760889, 2011.

F. Kunz and W. Stummvoll, Plasma phosphatidylethanolamineea better indicator in the predictability of atherosclerotic complications?, Atherosclerosis, vol.13, issue.3, 1971.

P. J. Meikle, G. Wong, D. Tsorotes, C. K. Barlow, J. M. Weir et al., Plasma lipidomic analysis of stable and unstable coronary artery disease, Arterioscler. Thromb. Vasc. Biol, vol.31, issue.11, 2011.

P. J. Meikle, G. Wong, C. K. Barlow, J. M. Weir, M. A. Greeve et al., Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes, PLoS One, vol.8, issue.9, p.24086336, 2013.

M. Dashti, W. Kulik, F. Hoek, E. C. Veerman, M. P. Peppelenbosch et al., A phospholipidomic analysis of all defined human plasma lipoproteins, Pubmed Central, vol.1, p.139, 2011.